{"id":"W4408207552","doi":"10.1080/14796694.2025.2471200","title":"Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPC","year":2025,"lang":"en","type":"review","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Enzalutamide; Medicine; Docetaxel; Abiraterone acetate; Abiraterone; Oncology; Internal medicine; Pharmacology; Prostate cancer; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003800099,0.0004941706,0.004344922,0.0007160488,0.00005971114,0.00001425455,0.0002127119,0.0009130837,0.00008090086],"category_scores_gemma":[0.0000602764,0.0003542241,0.0002467835,0.0007109625,0.0002250519,0.00004689125,0.0002259762,0.001242109,0.00001957582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001121661,"about_ca_system_score_gemma":0.002315145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001585402,"about_ca_topic_score_gemma":0.0007976177,"domain_scores_codex":[0.9972846,0.0004377413,0.0008962667,0.0005875154,0.0002696942,0.0005242031],"domain_scores_gemma":[0.9983455,0.0005749097,0.0004416392,0.0003839456,0.00008995507,0.0001640507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002400624,0.0003914014,0.0002118818,0.03981874,0.0008772356,0.000412149,0.00112661,0.000001521437,0.000007886076,0.0001770581,0.001694588,0.9528803],"study_design_scores_gemma":[0.01146577,0.001690231,0.0003806936,0.01112508,0.002036014,0.00007577522,0.0005800265,0.000005587957,0.00002742727,0.00004178943,0.972275,0.0002965968],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002428291,0.9889656,0.00000252639,0.0003937714,0.001242871,0.001847821,0.0001008754,0.00004250948,0.004975763],"genre_scores_gemma":[0.0007220549,0.9953147,0.0003262562,0.00003793022,0.0003544851,0.0002405937,0.0005515036,0.00004391521,0.002408579],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9705804,"threshold_uncertainty_score":0.999891,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09705332580578253,"score_gpt":0.4455255526695369,"score_spread":0.3484722268637544,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}